Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

iSpecimen Inc.

NASDAQ: ISPC · Industrial Applications and Services · 5 alerts · CIK 1558569

Share price
$0.6049Close, Nov 16
Market cap
$1.52M
Shares outstanding
2.52MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Commercial Physical & Biological ResearchSIC 8731

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All iSpecimen Inc. filings on SEC EDGAR ↗

6:32 AM ET 10-Q
Financial Results

iSpecimen Q3 2026 Results: Net Loss of $2.21M, Loss Narrows

For the nine months ended September 30, 2026, iSpecimen Inc. reported a net loss of $5.85 million on revenue of $551,983, a significant decrease from $1.88 million in revenue for the same period in 2025. The company strengthened its balance sheet through PIPE financings totaling $7.5 million and executed a 1-for-40 reverse stock split in April 2026.

Key figure
Net loss $2.21M
5:16 PM ET 8-K
Capital Raise

iSpecimen Capital Raise

iSpecimen Inc. entered into a securities purchase agreement with accredited investors for a private placement of 500 shares of Series D Convertible Preferred Stock at $800 per share. The offering generated gross proceeds of $400,000, which the company intends to use for working capital and general corporate purposes. E.F. Hutton & Co. served as the exclusive placement agent for the transaction.

Counterparty
E.F. Hutton & Co.
5:01 PM ET 8-K
M&A Deal

iSpecimen Signs $4.5M M&A Deal with Foldlab AI Ltd.

iSpecimen Inc. completed the acquisition of AI software assets from Foldlab AI Ltd. for an aggregate purchase price of $4.5 million, consisting of $750,000 in cash, $1.25 million in milestone payments, and $2.5 million in common stock. The acquired assets include a Disease-Associated Protein Discovery AI Agent and a Disease Trend Prediction and Monitoring AI Model, marking the company's entry into AI-powered drug discovery.

Value
$4.5M
Counterparty
Foldlab AI Ltd.
5:01 PM ET 8-K
Reverse Stock Split

iSpecimen Reverse Stock Split

iSpecimen Inc. stockholders approved an amendment to the company's Certificate of Incorporation to effect a reverse stock split. The approved ratio range is between 1-for-10 and 1-for-100, with the final ratio to be determined by the Board of Directors.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.